| NCT Number | NCT03892330 |
| Lead Sponsor | Shengjing Hospital |
| Conditions | 0.5-14 Year Old Children With Nephroblastoma |
| Enrollment | 120 participants |
| Start Date | 2019-06-01 |
| Primary Completion | 2020-12-31 (estimated) |
| Study Completion | 2045-06-30 (estimated) |
| Updated on ClinicalTrials.gov | 2019-03-27 |